Roche to challenge Pfizer with drug to enhance "good" cholesterol

10/21/2004 | Reuters

Roche Holding is challenging Pfizer in the effort to develop a drug focusing on the "good" type of cholesterol by licensing the JTT-705 experimental drug from Japan Tobacco. Pfizer's version is further along in the clinical-trial stage, but Roche plans to use the Japanese product to compete with Pfizer in the market for a cholesteryl ester transfer protein inhibitor.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID